Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Aethlon Medical Inc (AEMD) is the issuer in a Schedule 13G reporting Jane Street Group, LLC’s beneficial ownership of 35,819 common shares, or 5.0% of the class, with shared voting and dispositive power over 35,819 shares. Jane Street Capital, LLC and Jane Street Global Trading, LLC, identified as subsidiaries, separately report beneficial ownership of 6,845 shares (1.0%) and 28,974 shares (4.1%), respectively. Jeremy Kahn signed as an authorized signatory.
Key Figures
Beneficial ownership:35,819 sharesOwnership percentage:5.0%Shared voting power:35,819 shares+5 more
8 metrics
Beneficial ownership35,819 sharesJane Street Group, LLC; 5.0% of the class
Ownership percentage5.0%Jane Street Group, LLC
Shared voting power35,819 sharesJane Street Group, LLC
Shared dispositive power35,819 sharesJane Street Group, LLC
Beneficial ownership6,845 sharesJane Street Capital, LLC; 1.0% of the class
Ownership percentage1.0%Jane Street Capital, LLC
Beneficial ownership28,974 sharesJane Street Global Trading, LLC; 4.1% of the class
Ownership percentage4.1%Jane Street Global Trading, LLC
Key Terms
Amount beneficially owned, Shared Voting Power, Shared Dispositive Power
3 terms
Amount beneficially ownedfinancial
"Amount beneficially owned: 35,819.00"
Shared Voting Powertechnical
"Shared Voting Power 35,819.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Powertechnical
"Shared Dispositive Power 35,819.00"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many AEMD shares did Jane Street Group report beneficially owning?
Jane Street Group, LLC reported beneficial ownership of 35,819 Aethlon Medical common shares, equal to 5.0% of the class. It reported shared voting power and shared dispositive power over 35,819 shares, with zero sole voting power and zero sole dispositive power.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
AETHLON MEDICAL INC
(Name of Issuer)
Common Stock, $0.001 par value per share
(Title of Class of Securities)
00808Y703
(CUSIP Number)
10/06/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
00808Y703
1
Names of Reporting Persons
JANE STREET GROUP, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
35,819.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
35,819.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
35,819.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.0 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
CUSIP Number(s):
00808Y703
1
Names of Reporting Persons
Jane Street Capital, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
6,845.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
6,845.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,845.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.0 %
12
Type of Reporting Person (See Instructions)
BD
SCHEDULE 13G
CUSIP Number(s):
00808Y703
1
Names of Reporting Persons
Jane Street Global Trading, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
28,974.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
28,974.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
28,974.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.1 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
AETHLON MEDICAL INC
(b)
Address of issuer's principal executive offices:
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CALIFORNIA, 92121.
Item 2.
(a)
Name of person filing:
Jane Street Group, LLC
Jane Street Capital, LLC
Jane Street Global Trading, LLC
(b)
Address or principal business office or, if none, residence:
Jane Street Group, LLC
250 Vesey Street 3rd Floor
New York, NY 10281
Jane Street Capital, LLC
250 Vesey Street 3rd Floor
New York, NY 10281
Jane Street Global Trading, LLC
250 Vesey Street 3rd Floor
New York, NY 10281
(c)
Citizenship:
See Item 4 of Cover Page
(d)
Title of class of securities:
Common Stock, $0.001 par value per share
(e)
CUSIP Number(s):
00808Y703
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
35,819.00
(b)
Percent of class:
5.0%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
35,819.00
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
35,819.00
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
Subsidiary
Jane Street Capital, LLC
Jane Street Global Trading, LLC
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
